VMLTX | VMLUX | VMLTX / VMLUX | |
Total Expense Ratio | 0.17 | 0.09 | 189% |
Annual Report Gross Expense Ratio | 0.17 | 0.09 | 189% |
Fund Existence | 38 years | 24 years | - |
Gain YTD | 0.646 | 0.646 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 50000 | 6% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 31B | 31B | 100% |
Annual Yield % from dividends | 2.92 | 3.00 | 97% |
Returns for 1 year | 1.21 | 1.21 | 100% |
Returns for 3 years | 1.85 | 1.85 | 100% |
Returns for 5 years | -2.17 | -2.16 | 100% |
Returns for 10 years | -0.33 | -0.31 | 104% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPXX | 17.97 | 0.13 | +0.73% |
Nuveen S&P 500 Dynamic Overwrite Fund | |||
HCOW | 23.56 | 0.09 | +0.38% |
Amplify COWS Covered Call ETF | |||
RIGS | 23.15 | 0.01 | +0.06% |
RiverFront Strategic Income ETF | |||
THNR | 22.98 | N/A | -0.01% |
Amplify Weight Loss Drug & Treatment ETF | |||
BWX | 23.38 | -0.05 | -0.21% |
SPDR® Blmbg Intl Trs Bd ETF |